Phase Biolabs Analysis
What is Phase Biolabs?
Phase Biolabs transforms CO2 emissions into valuable chemicals and fuels using patented gas fermentation technology.
Employees
10
Founded
2020
Revenue
$0-5M
Company Stage
Pre-Seed
YC Batch
W22
Product Features & Capabilities
- transforming waste CO2 into valuable chemicals and fuels, gas fermentation process using patented microbes, retrofits on existing setups, works with any CO2 source, microorganisms that are six times more efficient and 100 times faster at converting CO2 into electrofuels.
Who are the founders of Phase Biolabs
DO
David Ortega
Founder & CTO
Investors
- Breakthrough Energy
- Asymmetry Ventures
- Transition Global
- Zillionize
- Y Combinator
Market Focus
Phase Biolabs primarily focuses on the biotechnology industry, specifically in the area of transforming CO2 emissions into valuable products through gas fermentation processes that produce chemicals and fuels.
Competitors Overview
Phase Biolabs operates in the biotechnology sector, focusing on converting waste CO2 emissions into valuable chemicals and fuels. Its main competitors include:
- Evonik: A leading specialty chemicals company that collaborates with Siemens to convert CO2 into specialty chemicals using renewable
Business Model
Revenue from selling CO2 conversion technology and sustainable chemical products to emitters.
See something that needs updating? Suggest edits to this profile.